Abstract |
Of 3,004 gram-negative bacilli collected from intra-abdominal infections in the Asia-Pacific region during 2007, 42.2% and 35.8% of Escherichia coli and Klebsiella spp., respectively, were extended-spectrum beta-lactamase (ESBL) positive. Moreover ESBL rates in India for E. coli, Klebsiella pneumoniae, and Klebsiella oxytoca were 79.0%, 69.4%, and 100%, respectively. ESBL-positive E. coli rates were also relatively high in China (55.0%) and Thailand (50.8%). Ertapenem and imipenem were the most active drugs tested, inhibiting over 90% of all species, including ESBL-positive isolates with the exception of Pseudomonas aeruginosa isolates (<90% susceptible to all study drugs) and ESBL-positive Klebsiella pneumoniae isolates (<90% susceptible to all study drugs except imipenem). Quinolones achieved 90% inhibition levels only against ESBL-negative K. pneumoniae and ESBL-negative K. oxytoca. A decline in ampicillin-sulbactam activity was noted, with only 34.5% of all Enterobacteriaceae inhibited in this study.
|
Authors | Stephen P Hawser, Samuel K Bouchillon, Daryl J Hoban, Robert E Badal, Po-Ren Hsueh, David L Paterson |
Journal | Antimicrobial agents and chemotherapy
(Antimicrob Agents Chemother)
Vol. 53
Issue 8
Pg. 3280-4
(Aug 2009)
ISSN: 1098-6596 [Electronic] United States |
PMID | 19506060
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Anti-Bacterial Agents
- Quinolones
- beta-Lactams
- Imipenem
- beta-Lactamases
- Ertapenem
|
Topics |
- Anti-Bacterial Agents
(pharmacology)
- China
- Drug Resistance, Bacterial
- Ertapenem
- Escherichia coli
(drug effects, enzymology)
- Gram-Negative Bacteria
(drug effects, enzymology, isolation & purification)
- Gram-Negative Bacterial Infections
(microbiology)
- Imipenem
(pharmacology)
- India
- Klebsiella
(drug effects, enzymology)
- Quinolones
(pharmacology)
- Thailand
- beta-Lactamases
(metabolism)
- beta-Lactams
(pharmacology)
|